Clinical Trial Management Systems Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029

The limiting factors related to this market are that the clinical trial management software are vulnerable to several types of malicious attacks on the security and the required infrastructure demands constant IT support and replacement of hardware.

For appropriate understanding of this market, the report scope includes the types segment which is categorized as enterprise and site. Delivery modes include web-based, cloud based and on-premise clinical trial management systems. The components segments are classified as software and services. Market size and forecast for the segments are provided for the duration of the report 2019-2029.

The scope of this report has included the following geographical segments with their respective major countries which are enlisted as follows

• North America
• United States
• Canada
• Europe
• Rest of Europe
• Germany
• Rest of Europe
• Asia Pacific
• India
• Japan
• China
• Rest of Asia Pacific
• Latin America
• Rest of LATAM
• Brazil
• Mexico
• Middle East and Africa
  
• Rest of Middle East and Africa
• GCC

Proper importance has been given to understand the competitive environment currently existing among the key players with a pictorial illustration of competitive landscape. The scope of the report has also taken into consideration those major players that have a stronghold in the global clinical trial management systems. The major players in global clinical trial management systems market are Bio-Optronics, Inc., Merge Healthcare Incorporated, Bioclinica, DSG, Inc., Forte Research Systems, Inc., eClinForce, Inc., Medidata Solutions, Inc., MedNet Solutions, Inc., Oracle Corporation and PAREXEL International Corporation.

Based on type, the global clinical trial management systems market is categorized into

• Enterprise
• Site

The global clinical trial management systems market is driven by key factors such as rising number of research and development activites in the healthcare segment, and burgeoning requirement for the launch of novel drugs resulting in rising number of clinical trials. Major players involved in the designing of clinical trial management systems are constantly striving to overcome CTMS anomalies such as device software being exposed to several malicious attacks and low data storage capacity of the clinical trial management systems. Enterprise segment showcases tremendous growth due to key drivers such as rising adoption of enterprise clinical trial management systems by pharmaceutical, biotechnology and medical device industries. In addition rising number of strategic collaborations between major healthcare players and research institutes, and increasing outsourcing of the research activities will have a good influence on the market growth of CTMS. On site clinical trial management systems segment are expected to demonstrate promising growth and will be the fastest growing segment. Factors such as efficient support in day-to-day research activites related to feasibility studies and improving nature of CTMS by providing technical expertise of biostatisticians and database administrators drive the growth of this segment. The major players in clinical trial management systems market are Bio-Optronics, Inc., Bioclinica, DSG, Inc., eClinForce, Inc., Forte Research Systems, Inc., Medidata Solutions, Inc., MedNet Solutions, Inc., Merge Healthcare Incorporated, Oracle Corporation and PAREXEL International Corporation.

Based on component types, the global clinical trial management systems market is categorized into

• Software
• Services

At present, software segment holds the largest market share due to key drivers such as increasing volume of research data in the later phases of clinical trials that have a greater degree of complexity. This has resulted in greater demand for more comprehensive software. Technological advancement in the software segment where software relating to research activities are integrated with healthcare mobile apps giving leverage to the investigators to manage, deploy and streamline clinical data will thereby have a strong influence on the market growth of CTMS. Services promises good sales due to factors such as the burgeoning requirement of services from the healthcare segment such as mapping core areas in clinical research for project management. In addition the site and trial planning and managing useful information such as protocol visit frequency and case report forms drives the CTMS market. In addition, CTMS provide crucial services such as studying grants and management of financial disclosure to determine the ownership of the clinical research funding.

Based on delivery mode, the global clinical trial management systems market is categorized into

• Web-based
• Cloud-based
• On-premise

Clinical trial management systems is very useful as it provides refined research data to a business intelligence system and functions as a digital dashboard for the operator. CTMS has tremendous potential in dealing with research data as it is helping in managing and streamlining research data and also aids in tracking deadlines and milestones. On-premise delivery mode dominates the market due to factors such as increasing adoption by the major players in the healthcare domain as it facilitates immediate access to research data as it is a well maintained IT infrastructure with maximum IT security and support. Cloud-based delivery mode is anticipated to be the fastest growing market due to its large storage capacity, allows the consumers to gain immediate access to vital research data and less maintenance cost incurred.

For the purpose of this study, the global clinical trial management systems market is categorized into the following regional and country specific markets:

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• GCC
• Rest of Middle East and Africa

North America was observed to be the largest clinical trial management systems market in the base year 2019. Dominance of North America is mainly attributed to the presence of key drivers such as rising prevalence of chronic diseases, increasing public health awareness and presence of major players pioneering in creation of clinical trial management systems. The market growth in Europe is mainly attributed to increase in research and development activities in the healthcare sector and memorandum of understanding between government health agencies and research institutes for launch of novel drug molecules. Asia Pacific has steady growth as a result of increasing outsourcing of research activities and existence of well-developed IT industry actively involved in providing software and services for the clinical trial management. Moreover, factors such as increasing enrollment of patients for clinical trials and regional government health agencies actively involved in sponsoring research for pipeline molecules are going to fuel the rapid growth of clinical trial management systems market in Latin America, and Middle East and Africa in the near future.


This product will be delivered within 2 business days.